Zeox Corporation (ZOX) Quote

Stocks Swoon After Weak $42 Billion Treasury Sale: Markets Wrap
Rita Nazareth Wed, Aug 7, 2024

(Bloomberg) -- The rapid slide in US stocks that followed a weak $42 billion sale of Treasuries underscored the fragility of global financial markets in the wake of historic volatili

Here we go

https://idahocapitalsun.com/2024/08/07/latter-day-saints-democrats-and-republicans-join-forces-to-support-harris/

More evidence these illegals are NOT here as refugee asylum seekers.

https://x.com/hernandoarce/status/1821320524301041838

re VTLE, SMCI is targeting 50 billion revenue

annually in their Investor Presentation

posted on their website...

https://s25.q4cdn.com/632471818/files/doc_financials/2024/q4/Earnings-Deck-Q4FY24-V5-w-2-of-2-at-end.pdf

They were targeting 25

America does not hold public hangings anymore.

And yet some wanted to bring 'em back on January 6...

The 2024 numbers are 71 positive opinions, 4 negative opinions, and 4 withdrawals. This equates to a 90 percent favorable rate so far this year. This is on the high side of the historic range, but it's a fairly small sample size.

$LPSN LivePerson and Sycurio Partnership: A New Era for Conversational AI and Secure Payments

ParlayYouSay here with an important update after my most recent LPSN DD post.

LivePerson, a leader in conversational AI, has partnered with Sycurio, a company known for its rob

$LPSN LivePerson and Sycurio Partnership: A New Era for Conversational AI and Secure Payments

ParlayYouSay here with an important update after my most recent LPSN DD post.

LivePerson, a leader in conversational AI, has partnered with Sycurio, a company known for its rob

SMCI posted over 80% increase in net

earnings on a year to year comparison

for 4th quarter at those nasty lower margins...

SMCI posted over 170% yearly gain

in shareholder equity...

https://finance.yahoo.com/news/supermicro-a

Other than low gas prices and overall lower prices on anything

Bashing a stock that can only be sold is shady AF.

Hows all the carbon filtering going for uhf? Are they designing packages for the home aquarium market? How about swimming pools?
Could be very lucrative.
About as productive as their other carbon marketing has been.

So CHMP statistic this year so far: 98.6% Approved???!!! Wow
Don't attack me; you are right. : ) Not you, chrismiss_everyday.

Positive opinions on new medicines: 71 total
Negative opinions on new medicines: 1 total (for Leqembi)

ASII $$$ ABOUT TO BLOW-UP THURSDAY AND FRIDAY, AND THE NEXT 2-3 WEEKS, I THINK YOUR 100% RIGHT Caddy, WE COULD SEE .005 FIRST, THEN .05, & THEN 0.50+ REAL QUICK HERE.!!

NorCal your post is full of disinformation. I have nothing to do with mgt and am as disappointed as anyone else that I’ve wasted 13 years on this go nowhere investment. The fact that I don’t whine about it everyday doesn't mean I’m happy with how things turned out or the time I wasted. I’m just too

Seriously though ever since voyager went down. (I'm now much smarter moving things to wallets) but how do I buy CKB in united states now? I'm not great yet at figuring out the swaps and stuff.

Update on l-r-dg. Bigfoot sent an email to me that he's still waiting for communication from biscardi or his lawyer. Bigfoot mentioned he and family were invited to Paris for the Olympics and will be on an extended vacation there looking at a possible new forest habitat. Apparently a rich relative l

The one new deal per year is not a gross exaggeration as you claim.

It is indeed accurate and the press releases are there for everyone to see. Remember a new collaboration contract for a new therapeutic with an existing partner certainly counts as a new deal.

Wonder how much NVDA has in T-bills

with the DOJ coming to chat?...

Probably not keeping over 30 billion

in just banks...

so we watch...LJ

Clive's note is being bought back? Nope, never happened.

270 million more shares dumped on investors since April - how much left? Another $4 or $5 million in Clive's pocket.

https://x.com/electroboyusa/status/1821076042196635830

Interesting that two elite upper echelon of biotech investors (Investor and Frrol) with access to the same information, can be so far apart in their assessment of Anavex chances of EMA approval.

Peanuts...

Precisely.